News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,378 Results
Type
Article (5029)
Company Profile (17)
Press Release (220332)
Section
Business (82296)
Career Advice (461)
Deals (15056)
Drug Delivery (8)
Drug Development (19067)
Employer Resources (30)
FDA (3677)
Job Trends (3905)
News (120220)
Policy (7504)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (294)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14799)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3694)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2864)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (438)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16017)
Collaboration (165)
Compensation (167)
Complete response letters (2)
COVID-19 (302)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (504)
Depression (5)
Diabetes (40)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40810)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37742)
Executive appointments (304)
FDA (3924)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (179)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (411)
Guidances (16)
Healthcare (5036)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1123)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3859)
Medtech (3860)
Mergers & acquisitions (7434)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (907)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24590)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4775)
Phase II (6955)
Phase III (5545)
Pipeline (541)
Policy (8)
Postmarket research (625)
Preclinical (1871)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1882)
Recruiting (8)
Regulatory (5113)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (688)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6911)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (5)
Last 7 days (118)
Last 30 days (661)
Last 365 days (10036)
2025 (2825)
2024 (11044)
2023 (13205)
2022 (18690)
2021 (19730)
2020 (18264)
2019 (13239)
2018 (10221)
2017 (10018)
2016 (9188)
2015 (12140)
2014 (9620)
2013 (7717)
2012 (8341)
2011 (8805)
2010 (8640)
Location
Africa (185)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11463)
Australia (1608)
California (1902)
Canada (688)
China (71)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24684)
Florida (267)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (218)
Massachusetts (1528)
Michigan (86)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (554)
New Mexico (5)
New York (466)
North Carolina (321)
North Dakota (2)
Northern California (907)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (338)
Puerto Rico (1)
Rhode Island (12)
South America (276)
South Carolina (4)
Southern California (688)
Tennessee (38)
Texas (222)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
225,378 Results for "sartorius corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.
June 6, 2024
·
3 min read
Press Releases
Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
November 22, 2024
·
3 min read
Press Releases
VectorBuilder and Sartorius Sign Strategic Cooperation Agreement to Advance Biopharmaceutical Innovation
November 27, 2024
·
2 min read
Business
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.
August 17, 2023
·
6 min read
Sartorius to Host 2023 Sartorius Summit Event
Event will feature industry leaders, cutting-edge technology in cell line development CAMBRIDGE-March 16, 2023- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will host the Sartorius Summit:
March 16, 2023
·
2 min read
Business
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.
June 5, 2023
·
4 min read
Sartorius names Maurice Phelan as new President for North America
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has announced Maurice Phelan has assumed the role of President of Sartorius North America.
January 3, 2023
·
2 min read
Biotech Bay
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, shared new data that demonstrates the ability to improve the recovery of full AAV capsids during anion-exchange purification, which will help gene therapy companies streamline the downstream processing workflow.
July 20, 2023
·
4 min read
Business
Preliminary results 2022 of Sartorius Stedim Biotech
Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.
January 26, 2023
·
11 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
1 of 22,538
Next